Interaction of inducible nitric oxide synthase and cyclooxygenase-2 inhibitors in formalin-induced nociception in mice

European Journal of Pharmacology

Volumn 492, Issue 2-3, 2004, Pages 117-122

  Dudhgaonkar, Shailesh P ^a   Kumar, Dinesh ^a   Naik, Ajit ^a   Devi, Aruna R ^a   Bawankule, Dnyaneshwar U ^a   Tandan, Surendra K ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

(Mouse); Aminoguanidine hydrochloride; Formalin test; Rofecoxib; Synergism

Indexed keywords

AMINOGUANIDINE; ANTINOCICEPTIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; FORMALDEHYDE; NITRIC OXIDE SYNTHASE INHIBITOR; ROFECOXIB;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FOOT; LICKING; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FORMALDEHYDE; GUANIDINES; LACTONES; MALE; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PAIN; PAIN MEASUREMENT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONES;

EID: 2642561835     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.03.021     Document Type: Article

References (35)

1. Aley K.O., McCarter G., Levine J.D. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. 18:1998;7008-7014
2. Carter W.H. Jr., Gennings C., Staniwalis J.B., Campbell E.D., White K.L. A statistical approach to the construction and analysis of isobolograms. J. Am. Coll. Toxicol. 7:1998;74-79
3. Chan C.C., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier D., Evans J., Ford-Hutchinson A.W., Forrest M.J., Gauthier J.Y., Gordon R., Gresser M., Guay J., Kargman S., Kennedy B., Leblanc Y., Leger S., Mancini J., O'Neill G.P., Ouellet M., Pathick D., Percival M.D., Perrier H., Prasit P., Rodger I., Tagari P., Therien M., Vickers P., Visco D., Wang Z., Webb J., Wong E., Xu L.J., Young R.N., Zamboni R., Riendeau D. Rofecoxib: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J. Pharmacol. Exp. Ther. 290:1999;551-560
4. Clancy R.M., Abramson S.B. Nitric oxide: a novel mediator of inflammation. Proc. Soc. Exp. Biol. Med. 210:1995;93-101
5. 2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol. 110:1993;193-198
6. Foltin R.W., Woolverton W.L., Schuster C.R. Effects of psychomotor stimulants, alone and in pairs, on milk drinking in the rat after intraperitoneal and intragastric administration. J. Pharmacol. Exp. Ther. 226:1983;411-418
7. Gaffen Z., Philip A., Bland-Ward, Pitchr A., Wallace P., Moore P.K. Augmented anti-nociception following 7-nitro indazole and flurbiprofen in the conscious mouse. Eur. J. Pharmacol. 271:1994;445-452
8. Gennings C., Carter W.H. Jr., Campbell E.D., Staniswalis J.G., Martin T.J., Martin B.R., White K.L. Jr. Isobolographic characterization of drug interactions incorporating biological variability. J. Pharmacol. Exp. Ther. 252:1990;208-217
9. Gessner P.K. A straight forward method for the study of drug interactions: an isobolographic analysis primer. J. Am. Coll. Toxicol. 7:1988;987-1012
10. Hughes S.R., Williams T.J., Brain S.D. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur. J. Pharmacol. 191:1990;481-484
11. Hunskaar S., Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 30:1987;103
12. Jose C., Rocha S., Magno E.B.P., Jancar S., Cunha F.D.Q., Ribeiro R.D.A., da Rocha F.A.C. Dual effect of nitric oxide in articular inflammatory pain in zymosan-induced arthritis in rats. Br. J. Pharmacol. 136:2002;588-596
13. Kawabata A., Kukuzumi Y., Fukushima Y., Takagi H. Antinociceptive effect of L-arginine on carrageenan-induced hyperalgesia in rats. Possible involvement of central opiodergic systems. Eur. J. Pharmacol. 28:1992;153-158
14. Korhonen R., Lahti A., Hamalainen M., Kankaanranta H., Moilanen E. Dexamethasone inhibits inducible nitric oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol. Pharmacol. 62:2002;698-704
15. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., Herschman H.R. TIS 10, a phorbolester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266:1991;12866-12872
16. Lyons C.R. The role of nitric oxide in inflammation. Adv. Immunol. 60:1995;323-371
17. Marcinkiewicz J., Grabowaska A., Chain B. Nitric oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25:1995;947-951
18. Masuda Y., Utsui Y., Shiraishi Y., Karasawa T., Yoshida K.S. Evidence for a synergistic interaction between phenytoin and phenobarbital in experimental animals. J. Pharmacol. Exp. Ther. 217:1981;805-811
19. Mitchell J.A., Kohlhaas K.L., Sorentino R., Warner T.D., Murad F., Vane J.R. Induction by endotoxin of nitric oxide synthase in the rat mesentery artery: lack of effect on action of vasoconstrictors. Br. J. Pharmacol. 109:1993;265-270
20. Moore P.K., Wallace P., Gaffen Z., Hart S.L., Babbedge R.C. Characterization of the novel nitric oxide synthase inhibitor 7-nitroindazole and related indazoles: anti-nociceptive and cardiovascular effects. Br. J. Pharmacol. 110:1993;219-224
21. Morgan C.V.J., Babbedge R.C., Gaffen Z., Wallace P., Hart S.L., Moore P.K. Synergistic anti-nociceptive effect of L-NGnitro arginine methyl ester (L-NAME) and flurbiprofen in the mouse. Br. J. Pharmacol. 106:1992;493-497
22. Nelson A.C., Kursar T.A. Interactions among plant defense compounds: a method for analysis. Chemoecology. 9:1999;81-92
23. Newton R., Seybold J., Kuitert L.M.E., Bergmann M., Barnes P.J. Repression of cyclo-oxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and posttranscriptional mechanisms involving loss of polyadenylated mRNA. J. Biol. Chem. 273:1998;32312-32321
24. Nussler A.K., Billiar T.R. Inflammation, immunoregulation and inducible nitric oxide synthase. J. Leukoc. Biol. 2:1993;171-178
25. Ogden J.E., Moore P.K. Inhibition of nitric oxide synthase potential for a novel class of therapeutic agents? Trends Biotechnol. 13:1995;70-78
26. O'Neill G.P., Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330:1993;156-160
27. Palmer R.M.J., Asthon D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666
28. Raz A., Wyche A., Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc. Natl. Acad. Sci. U. S. A. 86:1989;1657-1661
29. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 90:1993;7240-7244
30. Salvemini D., Mannig P.T., Zweifel B.S., Seibert K., Connor J., Currie M.G., Needleman P., Masferrer J.L. Dual inhibition of nitric oxide and prostaglandin production contributes to antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 96:1995;301-308
31. Sautebin I., Ialenti A., Ianaro A., Dirosa M. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br. J. Pharmacol. 114:1995;323-328
32. Shibata M., Ohkubo T., Takahashi H., Inuki R. Modified formalin test: characteristic biphasic pain response. Pain. 38:1989;347-352
33. Vane J.R., Botting R.M. New insights into the mode of action of antiinflammatory drugs. Inflamm. Res. 44:1995;1-10
34. Wheeler-Aceto H., Cowan A. Neurogenic and tissue-mediated components of formalin-induced oedema: evidence for supraspinal regulation. Agents Actions. 34:1991;264-269
35. Wheeler-Aceto H., Porreca F., Cowan A. The rat paw formalin test: comparison of noxious agent. Pain. 40:1990;229-239